Pancreatic neuroendocrine tumors (PNETs) are rare pancreatic neoplasms. About 40-80% of patients with PNET are metastatic at presentation, usually involving the liver (40-93%). Liver metastasis represents the most significant prognostic factor. The aim of this study is to present an up-to-date review of treatment options for patients with liver metastases from PNETs.
Treatment options for PNET liver metastases. a systematic review / Nigri, Giuseppe; Petrucciani, Niccolò; Debs, Tarek; Mangogna, Livia Maria; Crovetto, Anna; Moschetta, Giovanni; Persechino, Raffaello; Aurello, Paolo; Ramacciato, Giovanni. - In: WORLD JOURNAL OF SURGICAL ONCOLOGY. - ISSN 1477-7819. - 16:1(2018), pp. 142-152. [10.1186/s12957-018-1446-y]
Treatment options for PNET liver metastases. a systematic review
Nigri, Giuseppe
;Petrucciani, Niccolò;Mangogna, Livia Maria;Moschetta, Giovanni;Persechino, Raffaello;Aurello, Paolo;Ramacciato, Giovanni
2018
Abstract
Pancreatic neuroendocrine tumors (PNETs) are rare pancreatic neoplasms. About 40-80% of patients with PNET are metastatic at presentation, usually involving the liver (40-93%). Liver metastasis represents the most significant prognostic factor. The aim of this study is to present an up-to-date review of treatment options for patients with liver metastases from PNETs.| File | Dimensione | Formato | |
|---|---|---|---|
|
Nigri_Treatment_2018.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
894.65 kB
Formato
Adobe PDF
|
894.65 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
